Stem cell therapy for Parkinson’s disease

References

• Olanow CW, Tatton WG. Etiology and pathogenesis of Parkinson’s disease. Annu. Rev. Neurosci.22, 123–144 (2000).
   Web of Science ®Google Scholar
• Bergman H, Deuschl G. Pathophysiology of Parkinson’s disease: from clinical neurology to basic neuroscience and back. Mov. Disord.17(Suppl. 3), S28–S40 (2002).
   PubMed Web of Science ®Google Scholar
• Dostrovsky JO, Hutchison WD, Lozano AM. The globus pallidus, deep brain stimulation, and Parkinson’s disease. Neuroscientist8, 284–290 (2002).
   PubMed Web of Science ®Google Scholar
• Miyasaki JM, Martin W, Suchowersky O, Weiner WJ, Lang AE. Practice parameter: initiation of treatment for Parkinson’s disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology58, 11–17 (2002).
   PubMed Web of Science ®Google Scholar
• Lindvall O, Kokaia Z, Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders – how to make it work. Nat. Med.10, S42–S50 (2004).
   PubMed Web of Science ®Google Scholar
• Gage FH. Mammalian neural stem cells. Science287, 1433–1438 (2000).
   PubMed Web of Science ®Google Scholar
• Doetsch FA. A niche for adult neural stem cells. Curr. Opin. Genet. Dev.13, 543–550 (2003).
   PubMed Web of Science ®Google Scholar
• Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl Acad. Sci. USA78, 7634–7638 (1981).
   PubMed Web of Science ®Google Scholar
• Hauser RA, Freeman TB, Snow BJ et al. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch. Neurol.56, 179–187 (1999).
   PubMed Web of Science ®Google Scholar
• Piccini P, Brooks DJ, Björklund A et al. Dopamine release from nigral transplants visualized in vivo in a Parkinson’s patient. Nat. Neurosci.2, 1137–1140 (1999).
   PubMed Web of Science ®Google Scholar
• Lindvall O, Hagell P. Clinical observations after neural transplantation in Parkinson’s disease. Prog. Brain Res.127, 299–320 (2000).
   PubMedGoogle Scholar
• Freed CR, Greene PE, Breeze RE et al. Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. N. Engl. J. Med.344, 710–719 (2001).
   PubMed Web of Science ®Google Scholar
• Olanow CW, Goetz CG, Kordower JH et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson’s disease. Ann. Neurol.54, 403–414 (2003).
   PubMed Web of Science ®Google Scholar
• Ma Y, Feigin A, Dhawan V et al. Dyskinesia after fetal cell transplantation for parkinsonism: a positron emission tomography (PET) study. Ann. Neurol.52, 628–634 (2002).
   PubMed Web of Science ®Google Scholar
• Mukhida K, Baker KA, Sadi D, Mendez I. Enhancement of sensorimotor behavioral recovery in hemiparkinsonian rats with intrastriatal, intranigral, and intrasubthalamic nucleus dopaminergic transplants. J. Neurosci.21, 3521–3530 (2001).
   PubMed Web of Science ®Google Scholar
• Mendez I, Sanchez-Pernaute R, Cooper O et al. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson’s disease. Brain128, 1498–1510 (2005).
   PubMed Web of Science ®Google Scholar
• Carpenter MK, Cui X, Hu Z-Y et al. In vitro expansion of a multipotent population of human neural progenitor cells. Exp. Neurol.158, 265–278 (1999).
   PubMed Web of Science ®Google Scholar
• Ostenfeld T, Caldwell MA, Prowse KR, Linskens MH, Jauniaux E, Svendsen CN. Human neural precursor cells express low levels of telomerase in vitro and show diminishing cell proliferation with extensive axonal outgrowth following transplantation. Exp. Neurol.164, 215–226 (2000).
   PubMed Web of Science ®Google Scholar
• Palmer TD, Schwartz PH, Taupin P, Kaspar B, Stein SA, Gage FH. Progenitor cells from human brain after death. Nature411, 42–43 (2001).
   PubMed Web of Science ®Google Scholar
• Vescovi AL, Parati EA, Gritti A et al. Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of trans-plantable human neural stem cell lines by epigenetic stimulation. Exp. Neurol.156, 71–83 (1999).
   PubMed Web of Science ®Google Scholar
• Fricker RA, Carpenter MK, Winkler C, Greco C, Gates MA, Björklund A. Site-specific migration and neural differentiation of human neural progenitor cells after transplantation in the adult rat brain. J. Neurosci.19, 5990–6005 (1999).
   PubMed Web of Science ®Google Scholar
• Hitoshi S, Tropepe V, Ekker M, van der Kooy D. Neural stem cell lineages are regionally specified, but not committed, within distinct compartments of the developing brain. Development129, 233–244 (2002).
   PubMed Web of Science ®Google Scholar
• Jain M, Armstrong RJ, Tyers P, Barker RA, Rosser AE. GABAergic immunoreactivity is predominant in neurons derived from expanded human neural precursor cells in vitro. Exp. Neurol.182, 113–123 (2003).
   PubMed Web of Science ®Google Scholar
• Ostenfeld T, Joly E, Tai Y-T et al. Regional specification of rodent and human neurospheres. Dev. Brain Res.134, 43–55 (2002).
   PubMedGoogle Scholar
• Storch A, Paul G, Csete M et al. Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells. Exp. Neurol.170, 317–325 (2001).
   PubMed Web of Science ®Google Scholar
• Sánchez-Pernaute R, Studer L, Bankiewicz KS, Major EO, McKay RD. in vitro generation and transplantation of precursor-derived human dopamine neurons. J. Neurosci. Res.65, 284–288 (2001).
   PubMed Web of Science ®Google Scholar
• Horiguchi S, Takahashi J, Kishi Y et al. Neural precursor cells derived from human embryonic brain retain regional specificity. J. Neurosci. Res.75, 817–824 (2004).
   PubMed Web of Science ®Google Scholar
• Lee S-H, Lumelsky N, Studer L, Auerbach JM, McKay RD. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat. Biotech.18, 675–679 (2000).
   PubMed Web of Science ®Google Scholar
• Kawasaki H, Mizuseki K, Nishikawa S et al. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron28, 31–40 (2000).
   PubMed Web of Science ®Google Scholar
• Björklund LM, Sánchez-Pernaute R, Chung S et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Natl Acad. Sci. USA99, 2344–2349 (2002).
   PubMed Web of Science ®Google Scholar
• Kim J-H, Auerbach JM, Rodriguez-Gómez J et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson’s disease. Nature418, 50–56 (2002).
   PubMed Web of Science ®Google Scholar
• Barberi T, Klivenyi P, Calingasan NY et al. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat. Biotech.21, 1200–1207 (2003).
   PubMed Web of Science ®Google Scholar
• Takagi Y, Takahashi J, Saiki H et al. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J. Clin. Invest.115, 102–109 (2005).
   PubMed Web of Science ®Google Scholar
• Deacon T, Dinsmore J, Constantini LC, Ratliff J, Isacson O. Blastula-stage stem cells can differentiate into dopaminergic and serotonergic neurons after transplantation. Exp. Neurol.149, 28–41 (1998).
   PubMed Web of Science ®Google Scholar
• Ying QL, Stavridis M, Griffiths D, Li M, Smith A. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monocultures. Nat. Biotech.21, 183–186 (2003).
   PubMed Web of Science ®Google Scholar
• Ben-Hur T, Idelson M, Khaner H et al. Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in parkinsonian rats. Stem Cells22, 1246–1255 (2004).
   PubMed Web of Science ®Google Scholar
• Reubinoff BE, Itsykson P, Turetsky T et al. Neural progenitors from human embryonic stem cells. Nat. Biotech.19, 1134–1140 (2001).
   PubMed Web of Science ®Google Scholar
• Zhang SC, Wernig M, Duncan ID, Brustle O, Thomson JA. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat. Biotech.19, 1129–1133 (2001).
   PubMed Web of Science ®Google Scholar
• Erdö F, Bührle C, Blunk J et al. Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. J. Cereb. Blood Flow Metab.23, 780–785 (2003).
   PubMed Web of Science ®Google Scholar
• Nishimura F, Yoshikawa M, Kanda S et al. Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells. Stem Cells21, 171–180 (2003).
   PubMed Web of Science ®Google Scholar
• Fukuda H, Takahashi J, Watanabe K et al. FACS-based purification of ES cell-derived neural precursors averts tumor formation after transplantation. Stem Cells24, 763–771 (2006).
   PubMed Web of Science ®Google Scholar
• Chung S, Shin BS, Hedlund E et al. Genetic selection of sox1GFP-expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation. J. Neurochem.97, 1467–1480 (2006).
   PubMed Web of Science ®Google Scholar
• Bieberich E, Silva J, Wang G, Krishnamurthy K, Condie BG. Selective apoptosis of pluripotent mouse and human stem cells by novel ceramide analogues prevents teratoma formation and enriches for neural precursors in ES cell-derived neural transplants. J. Cell Biol.167, 723–734 (2004).
   PubMed Web of Science ®Google Scholar
• Schierle GS, Hansson O, Leist M, Nicotera P, Widner H, Brundin P. Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat. Med.5, 97–100 (1999).
   PubMed Web of Science ®Google Scholar
• Perrier AL, Tabar V, Barberi T et al. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl Acad. Sci. USA101, 12543–12548 (2004).
   PubMed Web of Science ®Google Scholar
• Zeng X, Cai J, Chen J et al. Dopaminergic differentiation of human embryonic stem cells. Stem Cells22, 925–940 (2004).
   PubMed Web of Science ®Google Scholar
• Schulz TC, Noggle SA, Palmarini GM et al. Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. Stem Cells22, 1218–1238 (2004).
   PubMed Web of Science ®Google Scholar
• Yan Y, Yang D, Zarnowska ED et al. Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells23, 781–790 (2005).
   PubMed Web of Science ®Google Scholar
• Park CH, Minn YK, Lee JY et al. In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons. J. Neurochem.92, 1265–1276 (2005).
   PubMed Web of Science ®Google Scholar
• Brederlau A, Correia AS, Anisimov SV et al. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson’s disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells24, 1433–1440 (2006).
   PubMed Web of Science ®Google Scholar
• Ueno M, Matsumura M, Watanabe K et al. Neural conversion of ES cells by an inductive activity on human amniotic membrane matrix. Proc. Natl Acad. Sci. USA103, 9554–9559 (2006).
   PubMed Web of Science ®Google Scholar
• Roy NS, Cleren C, Singh SK, Yang L, Beal MF, Goldman SA. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat. Med.12, 1259–1268 (2006).
   PubMed Web of Science ®Google Scholar
• Sonntag KC, Pruszak J, Yoshizaki T, van Arensbergen J, Sanchez-Pernaute R, Isacson O. Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the BMP antagonist Noggin. Stem Cells25, 411–418 (2007).
   PubMed Web of Science ®Google Scholar
• Dezawa M, Kanno H, Hoshino M et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J. Clin. Invest.113, 1701–1710 (2004).
   PubMed Web of Science ®Google Scholar
• Medicetty S, Bledsoe AR, Fahrenholtz CB, Troyer D, Weiss ML. Transplantation of pig stem cells into rat brain: proliferation during the first 8 weeks. Exp. Neurol.190, 32–41 (2004).
   PubMed Web of Science ®Google Scholar
• Lie DC, Colamarino SA, Song HJ. Wnt signalling regulates adult hippocampal neurogenesis. Nature437, 1370–1375 (2005).
   PubMed Web of Science ®Google Scholar
• Arvidsson A, Collin T, Kirik D et al. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat. Med.8, 963–970 (2002).
   PubMed Web of Science ®Google Scholar
• Parent JM, Vexler ZS, Gong C et al. Rat forebrain neurogenesis and striatal neuron replacement after focal stroke. Ann. Neurol.52, 802–813 (2002).
   PubMed Web of Science ®Google Scholar
• Jin K, Sun Y, Xie L et al. Directed migration of neuronal precursors into the ischemic cerebral cortex and striatum. Mol. Cell. Neurosci.24, 171–189 (2003).
   PubMed Web of Science ®Google Scholar
• Nakatomi H, Kuriu T, Okabe S et al. Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell110, 429–441 (2002).
   PubMed Web of Science ®Google Scholar
• Curtis MA, Penney EB, Pearson AG et al. Increased cell proliferation and neurogenesis in the adult human Huntington’s disease brain. Proc. Natl Acad. Sci. USA100, 9023–9027 (2003).
   PubMed Web of Science ®Google Scholar
• Jin K, Peel AL, Mao XO et al. Increased hippocampal neurogenesis in Alzheimer’s disease. Proc. Natl Acad. Sci. USA101, 343–347 (2004).
   PubMed Web of Science ®Google Scholar
• Zhao M, Momma S, Delfani K et al. Evidence for neurogenesis in the adult mammalian substantia nigra. Proc. Natl Acad. Sci. USA100, 7925–7930 (2003).
   PubMed Web of Science ®Google Scholar
• Cooper O, and Isacson O. Intrastriatal transforming growth factor a delivery to a model of Parkinson’s disease induces proliferation and migration of endogenous adult neural progenitor cells without differentiation into dopaminergic neurons. J. Neurosci.24, 8924–8931 (2004).
   PubMed Web of Science ®Google Scholar
• Chen Y, Ai Y, Slevin JR, Maley BE, Gash DM. Progenitor proliferation in the adult hippocampus and substantia nigra induced by glial cell line-derived neurotrophic factor. Exp. Neurol.196, 87–95 (2005).
   PubMed Web of Science ®Google Scholar
• Frielingsdorf H, Schwarz K, Brundin P, Mohapel P. No evidence for new dopaminergic neurons in the adult mammalian substantia nigra. Proc. Natl Acad. Sci. USA101, 10177–10182 (2004).
   PubMed Web of Science ®Google Scholar
• Kanatsu-Shinohara M, Inoue K, Lee J et al. Generation of pluripotent stem cells from neonatal mouse testis. Cell119, 1001–1012 (2004).
   PubMed Web of Science ®Google Scholar
• Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell126, 663–676 (2006).
   Google Scholar